semaglutide and cardiovascular disease Outcomes in Obesity without Diabetes 6 semaglutide Cardiovascular risk reduction

Our findings suggest these medications may be linked to improved short-term postoperative outcomes

PMID 11571281

One of the key roles of B12 is to aid in the conversion of food into glucose, the body's primary source of energy

The researchers took note of gastrointestinal adverse events that occurred among participants and found that the risk was similar for both medication groups

Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1E9 mouse model of Alzheimers disease

If that proves to be the case, doctors might someday optimize patients GLP-1 regimens for long-term cardiovascular benefits, not just for diabetes management and weight loss, researchers said in a report published online ahead of peer review